S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners

CASI Pharmaceuticals (CASI) Institutional Ownership

$4.90
-0.30 (-5.77%)
(As of 11/28/2023 ET)
Compare
Today's Range
$4.88
$5.49
50-Day Range
$2.00
$5.85
52-Week Range
$1.45
$5.94
Volume
47,382 shs
Average Volume
31,676 shs
Market Capitalization
$65.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

Institutional Ownership Changes (13F Filings) for CASI Pharmaceuticals (NASDAQ:CASI)

Current
Institutional Ownership
Percentage
14.62%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$783,669.38
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$281,833.39
Get CASI Insider Trade Alerts

Want to know when executives and insiders are buying or selling CASI Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CASI Institutional Buying and Selling by Quarter


CASI Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2023Geode Capital Management LLC22,221$55K0.0%-77.4%0.167%
8/11/2023Northern Trust Corp10,318$26K0.0%-65.4%0.077%
5/16/2023Susquehanna International Group LLP38,326$88K0.0%-33.2%0.288%
5/11/2023Wellington Shields Capital Management LLC180,143$0.42M0.1%N/A1.352%
5/11/2023Wellington Shields & Co. LLC139,315$0.32M0.1%N/A1.046%
2/14/2023Susquehanna International Group LLP57,395$100K0.0%+70.6%0.422%
11/15/2022Vanguard Group Inc.257,443$0.67M0.0%-15.9%1.892%
11/14/2022Renaissance Technologies LLC10,400$27K0.0%N/A0.076%
11/4/2022Prudential Financial Inc.11,000$29K0.0%N/A0.081%
9/16/2022Federated Hermes Inc.1,015,000$2.90M0.0%-90.0%7.460%
8/15/2022State Street Corp35,555$0.10M0.0%-90.0%0.261%
8/15/2022Wellington Shields Capital Management LLC213,250$0.61M0.1%-90.0%1.567%
8/12/2022Northern Trust Corp29,666$85K0.0%-89.9%0.218%
8/12/2022Ikarian Capital LLC132,014$0.38M0.1%-90.0%0.970%
8/12/2022Wellington Shields & Co. LLC145,317$0.42M0.1%-90.0%1.068%
8/12/2022Franklin Resources Inc.24,303$70K0.0%-93.3%0.179%
7/27/2022Bailard Inc.31,530$90K0.0%+25.6%0.232%
5/17/2022Virtu Financial LLC112,777$91K0.0%+39.6%0.083%
5/13/2022Renaissance Technologies LLC155,300$0.13M0.0%-89.3%0.114%
5/13/2022Vanguard Group Inc.3,061,331$2.48M0.0%-20.5%2.241%
5/12/2022Wellington Shields Capital Management LLC2,132,547$1.73M0.2%-2.6%1.561%
5/12/2022Citigroup Inc.73,117$59K0.0%N/A0.054%
5/11/2022Roundview Capital LLC38,112$31K0.0%-68.9%0.028%
5/9/2022Wellington Shields & Co. LLC1,453,190$1.18M0.4%+27.3%1.064%
2/16/2022Wellington Shields & Co. LLC1,141,190$0.91M0.2%-37.7%0.816%
2/15/2022Wellington Shields Capital Management LLC2,188,547$1.75M0.2%-3.1%1.566%
11/15/2021Marshall Wace LLP952,037$1.13M0.0%+325.6%0.681%
11/12/2021Renaissance Technologies LLC1,618,155$1.93M0.0%+4.6%1.158%
11/12/2021Geode Capital Management LLC944,729$1.12M0.0%+34.2%0.676%
11/12/2021Connor Clark & Lunn Investment Management Ltd.60,904$72K0.0%N/A0.044%
11/10/2021Goldman Sachs Group Inc.199,986$0.24M0.0%+32.3%0.143%
11/9/2021BlackRock Inc.1,165,942$1.39M0.0%-1.3%0.834%
8/26/2021Y Intercept Hong Kong Ltd16,246$25K0.0%N/A0.012%
8/25/2021Marshall Wace LLP223,709$0.35M0.0%N/A0.160%
8/17/2021Millennium Management LLC1,112,208$1.72M0.0%+1,211.7%0.796%
8/17/2021Price T Rowe Associates Inc. MD105,200$0.16M0.0%-32.3%0.075%
8/17/2021Prudential Financial Inc.16,600$26K0.0%N/A0.012%
8/17/2021Boothbay Fund Management LLC185,988$0.29M0.0%+14.8%0.133%
8/16/2021Squarepoint Ops LLC22,698$35K0.0%+107.4%0.016%
8/16/2021LMR Partners LLP30,360$47K0.0%N/A0.022%
8/16/2021Schonfeld Strategic Advisors LLC20,600$32K0.0%N/A0.015%
8/16/2021Charles Schwab Investment Management Inc.405,290$0.63M0.0%-20.0%0.290%
8/16/2021State Street Corp194,842$0.30M0.0%-81.3%0.139%
8/16/2021Tibra Equities Europe Ltd216,300$0.34M0.1%N/A0.155%
8/16/2021Goldman Sachs Group Inc.151,183$0.23M0.0%+143.6%0.108%
8/16/2021Marshall Wace LLP223,709$0.35M0.0%N/A0.160%
8/16/2021Wellington Shields Capital Management LLC2,258,264$3.50M0.4%+1.2%1.615%
8/13/2021Renaissance Technologies LLC1,546,306$2.40M0.0%+504.7%1.106%
8/13/2021Northern Trust Corp243,200$0.38M0.0%-70.4%0.174%
8/13/2021Geode Capital Management LLC703,888$1.09M0.0%-35.6%0.504%
8/13/2021Vanguard Group Inc.3,904,627$6.05M0.0%-7.6%2.793%
8/13/2021Bailard Inc.40,400$63K0.0%N/A0.029%
8/12/2021Dimensional Fund Advisors LP274,344$0.43M0.0%+4.6%0.196%
8/12/2021JPMorgan Chase & Co.191,523$0.30M0.0%+8.7%0.137%
8/12/2021Ergoteles LLC300,400$0.47M0.0%N/A0.215%
8/11/2021Bank of New York Mellon Corp36,436$56K0.0%-80.6%0.026%
8/11/2021BlackRock Inc.1,181,599$1.83M0.0%-70.5%0.845%
8/5/2021GSA Capital Partners LLP78,572$0.12M0.0%+377.9%0.056%
8/1/2021Sterneck Capital Management LLC40,000$47K0.0%N/A0.029%
7/31/2021Mosaic Family Wealth LLC17,500$27K0.0%N/A0.013%
5/19/2021Virtu Financial LLC66,106$0.16M0.0%+431.0%0.047%
5/19/2021Squarepoint Ops LLC10,943$26K0.0%N/A0.008%
5/18/2021Millennium Management LLC84,791$0.20M0.0%-34.3%0.061%
5/18/2021D. E. Shaw & Co. Inc.22,596$54K0.0%N/A0.016%
5/18/2021Cubist Systematic Strategies LLC21,100$51K0.0%+51.5%0.015%
5/17/2021Aristides Capital LLC63,250$0.15M0.1%N/A0.045%
5/17/2021Price T Rowe Associates Inc. MD155,288$0.37M0.0%+37.5%0.111%
5/17/2021Nuveen Asset Management LLC283,079$0.68M0.0%+20.4%0.202%
5/17/2021Goldman Sachs Group Inc.62,052$0.15M0.0%+109.8%0.044%
5/14/2021Ghost Tree Capital LLC650,000$1.56M0.4%N/A0.465%
5/14/2021Dimensional Fund Advisors LP262,374$0.63M0.0%+766.2%0.188%
5/14/2021Vident Investment Advisory LLC54,829$0.13M0.0%-39.3%0.039%
5/14/2021XTX Topco Ltd14,215$34K0.0%N/A0.010%
5/13/2021Barclays PLC55,269$0.13M0.0%+159.0%0.040%
5/13/2021Renaissance Technologies LLC255,700$0.61M0.0%+261.1%0.183%
5/13/2021Federated Hermes Inc.10,150,000$24.36M0.0%+45.0%7.261%
5/12/2021Northern Trust Corp820,622$1.97M0.0%-12.7%0.587%
5/12/2021Geode Capital Management LLC1,092,677$2.62M0.0%+14.1%0.782%
5/12/2021Wellington Shields & Co. LLC1,832,769$4.40M1.6%+1.1%1.311%
5/12/2021Wellington Shields Capital Management LLC2,231,765$5.36M0.5%+7.7%1.596%
5/12/20211492 Capital Management LLC79,743$0.19M0.1%N/A0.057%
5/12/2021JPMorgan Chase & Co.176,221$0.42M0.0%-4.2%0.126%
5/12/2021Panagora Asset Management Inc.125,747$0.30M0.0%N/A0.090%
5/10/2021GSA Capital Partners LLP16,442$39K0.0%-68.5%0.012%
5/7/2021BlackRock Inc.4,006,960$9.62M0.0%+4.6%2.866%
5/6/2021Quantitative Systematic Strategies LLC21,561$52K0.0%N/A0.015%
4/30/2021Creative Planning40,009$96K0.0%N/A0.029%
4/12/2021FNY Investment Advisers LLC49,400$0.12M0.0%N/A0.035%
3/26/2021Susquehanna International Group LLP13,290$39K0.0%-50.2%0.011%
3/8/2021Dimensional Fund Advisors LP30,290$89K0.0%N/A0.024%
2/25/2021Dimensional Fund Advisors LP30,290$89K0.0%N/A0.024%
2/24/2021Virtu Financial LLC12,450$37K0.0%-67.7%0.010%
2/23/2021Principal Financial Group Inc.14,414$43K0.0%N/A0.012%
2/19/2021JPMorgan Chase & Co.183,922$0.54M0.0%+281.1%0.148%
2/16/2021Price T Rowe Associates Inc. MD112,917$0.33M0.0%+53.7%0.091%
2/16/2021Charles Schwab Investment Management Inc.480,106$1.42M0.0%+1.7%0.387%
2/12/2021Federated Hermes Inc.7,000,000$20.65M0.0%+1.4%5.648%
2/12/2021The Manufacturers Life Insurance Company45,064$0.13M0.0%+121.5%0.036%
2/12/2021Ikarian Capital LLC1,268,154$3.74M0.2%-17.6%1.023%
2/12/2021Credit Suisse AG19,406$57K0.0%N/A0.016%
(Data available from 1/1/2016 forward)













CASI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CASI shares?

During the previous two years, 16 institutional investors and hedge funds held shares of CASI Pharmaceuticals. The most heavily invested institutionals were Federated Hermes Inc. ($2.90M), Vanguard Group Inc. ($0.67M), Wellington Shields Capital Management LLC ($0.42M), Ikarian Capital LLC ($0.38M), Wellington Shields & Co. LLC ($0.32M), State Street Corp ($0.10M), and Virtu Financial LLC ($91K).Learn more on CASI's institutional investors.

What percentage of CASI Pharmaceuticals stock is owned by institutional investors?

14.62% of CASI Pharmaceuticals stock is owned by institutional investors. Learn more on CASI's institutional investor holdings.

Which institutional investors have been buying CASI Pharmaceuticals stock?

The following institutional investors have purchased CASI Pharmaceuticals stock in the last 24 months: Wellington Shields & Co. LLC ($0.45M), Wellington Shields Capital Management LLC ($0.18M), Citigroup Inc. ($73.12K), Virtu Financial LLC ($31.97K), Susquehanna International Group LLP ($23.76K), Prudential Financial Inc. ($11K), and Renaissance Technologies LLC ($10.40K).

How much institutional buying is happening at CASI Pharmaceuticals?

Institutional investors have bought a total of 788,134 shares in the last 24 months. This purchase volume represents approximately $4.23M in transactions.

Which CASI Pharmaceuticals major shareholders have been selling company stock?

Of the 12 institutional investors that sold CASI Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Federated Hermes Inc. ($9.14M), Wellington Shields Capital Management LLC ($2.05M), Wellington Shields & Co. LLC ($2M), Renaissance Technologies LLC ($1.30M), Ikarian Capital LLC ($1.19M), Vanguard Group Inc. ($0.84M), and Franklin Resources Inc. ($0.34M).

How much institutional selling is happening at CASI Pharmaceuticals?

Institutional investors have sold a total of 17,629,650 shares in the last 24 months. This volume of shares sold represents approximately $65.97M in transactions.


This page (NASDAQ:CASI) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -